MarineMax stock
HZONYSEMarineMax, Inc., Consumer CyclicalISIN US5679081084
42Score 42 out of 100, Weak
Price and trend
81 / 100
Price history
+125% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 37% above it.
Since September 2025 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 63).
The price is at its 52-week high. Largest decline in 20 years: 95% (December 2006 to March 2009).
Chart figures for advanced users
- SMA 50$52.43
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$38.47
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)63
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$21.43
- The lowest closing price of the last twelve months.
- Resistance$52.79
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- MarineMax, Inc. belongs to the Specialty Retail industry (United States) and, with a market value of $1.17B, is number 63 of 86 companies in its industry on MEQIRI.
- In fiscal 2026 it reported revenue of $2.16B (down 6.3% year on year) and a loss of $8.2M.
- For fiscal 2027, analysts expect on average revenue of $2.27B (up 5%) and adjusted earnings per share of $1.59 (up 183.6%).
Show more
- MEQIRI Score 42 out of 100 (Weak): rank 529 of 596 in Consumer Cyclical, median 61.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
None of our strength checks applies.
Weaknesses
- Margin fallingOperating margin 2.4%, average of the prior years 8.4% (to 2025).Profitability 22
- Interest barely coveredOperating profit covers interest only 0.9 times.Stability 35
- Loss-makingLoss of $8.2M over the last 12 months.Fundamentals 43
Its standout strengths are momentum and technical analysis, while growth and valuation hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- price up very strongly over the past year
- weak fundamentals
- high price swings
What lowers it
- low growth grade (crashed less often in the backtest)
- price near its 52-week high
Valuation
Valuation signal
OvervaluedNo fair value can be calculated for this stock, so the signal follows the valuation grade.
Valuation metrics
No fair value can be calculated for this stock from the available figures.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2026, revenue fell 6.3% on the prior year. Revenue has stayed largely stable since 2007.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 35%, operating 2%, net 0%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 28 Jan 2027in 76 days
- Last reported
- 4 Nov 2026EPS reported −$0.08 (expected $0.04)below expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $1.59+0.9%
- Revenue
- $2.27B−0.5%
- Earnings per share
- $2.56−0.5%
- Revenue
- $2.35B−1.9%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: +10.4%Guidance for adjusted EBITDA ($110 million to $125 million) and earnings reaffirmed, but the same-store sales and industry outlook was lowered.
“Turning to guidance, after considering operating conditions, recent industry trends, retail performance, and other relevant factors, we are reaffirming our fiscal 2026 expectation for adjusted EBITDA for the year to be in the range of $110 million to $125 million, and adjusted net income to be in the range of …”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 23 Jul 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases or sales in the last 6 months.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at MarineMax
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
596 rated companies in Consumer Cyclical
- This company
- 42
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Specialty Retail
The next larger and next smaller companies by market value
- New Wave GroupNEWA-B.ST $1.37B65
- Revolve GroupRVLV $1.33B58
- ATRenewRERE $1.28B56
- RustaRUSTA.ST $1.22B64
- Fnac DartyFNAC.PA $1.14B52
- ApoteaAPOTEA.ST $1.04B72
- D-Market Elektronik Hizmetler ve Ticaret A.S.HEPS $968.08M46
- WinmarkWINA $967.18M68
ETFs that hold MarineMax
Held by 11 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Avantis Global Small Cap Value UCITS ETFAVWS | 0.06% | 0.39% | €1.49B |
| iShares S&P SmallCap 600 UCITS ETFIUS3 | 0.06% | 0.30% | €2.31B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.05% | 0.30% | €964.08M |
Show 5 more
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.04% | 0.30% | €4.28B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.04% | 0.30% | €2.22B |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.02% | 0.43% | €2.5B |
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.01% | 0.35% | €8.27B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.00% | 0.10% | €395.74M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Sep 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Oct 2025)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.